Yumei Luo

638 citations
32 papers · 469 indexed · h-index 16
Topics
CRISPR and Genetic Engineering (16 papers)Pluripotent Stem Cells Research (14 papers)Renal and related cancers (4 papers)
Journals
SHILAP Revista de lepidopterologíaBiochemical and Biophysical Research CommunicationsCell Reports

In The Last Decade

Yumei Luo

31 papers receiving 462 citations

Peers

Yumei Luo
Comparison fields: 5 of 68
  • Molecular Biology 337
  • Genetics 66
  • Cancer Research 60
  • Surgery 45
  • Biomedical Engineering 45
Replace Takako Shimada with:
Takako Shimada Japan
Gillian P. Johnson Ireland
Shu-Ching Huang United States
Soma Dash United States
Charlotte Brandt Sørensen Denmark
Bailey A. T. Weatherbee United States
Jenny L. Kerschner United States
Patrícia Diniz Portugal
Detu Zhu China
Yaoyong Chen China
Yumei Luo relative to Takako Shimada Japan Takako Shimada's profile →
Citations per field
00.5×3.8×
Takako Shimada · 1×
Citations per year

Countries citing papers authored by Yumei Luo

Since Specialization
Citations

This map shows the geographic impact of Yumei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumei Luo more than expected).

Fields of papers citing papers by Yumei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumei Luo. The network helps show where Yumei Luo may publish in the future.

Co-authorship network of co-authors of Yumei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yumei Luo. A scholar is included among the top collaborators of Yumei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumei Luo. Yumei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 3
4 16
5 21
6 16
7 6
8 20
9 7
10 31
11 40
12 22
13 21
14 17
15 13
16 15
17 32
18 9
19 5
20 26

About Yumei Luo

Yumei Luo is a scholar working on Reproductive Medicine, Molecular Biology and Genetics, having authored 32 papers that have together received 469 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (16 papers), Pluripotent Stem Cells Research (14 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Reproductive Medicine (42 citations), Molecular Biology (337 citations) and Cancer Research (60 citations). Yumei Luo has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Detu Zhu, Xiaofang Sun, Yong Fan, Yaoyong Chen, Xinjie Chen, Shu Wang, Qing Li, Lei Yue, Zhiqiang Xu and Bo Zhou. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026